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Abstract
Obesity is considered a worldwide epidemic disease. Many pathological conditions have been associated to obesity but the
evidence relating to impaired fertility in males with obesity are contrasting. The aim of this review was to evaluate the
interplay between obesity and male fertility, analyzing evidence from in vitro and in vivo studies to clinical trials. Obesity
seems to be responsible of secondary hypogonadism. Here, we propose a new classiﬁcation including central, peripheral and
testicular factors that may affect the hypothalamic-pituitary-gonadal axis. Moreover, some studies demonstrated a direct
action of obesity on sperm count and sperm characteristics, mediated by impaired Sertoli cells function, increased scrotal
temperature, oxidative stress and accumulation of toxic substances and liposoluble endocrine disruptors in fat tissue. Recent
studies have explored obesity-related epigenetic effects in sperm cells which may cause diseases in offspring. Moreover, not
only in females but also males, obesity has been linked to reduced outcomes of in vitro fertilization, with a reduction of
pregnancy rate and an increase of pregnancy loss. Finally, we reviewed the effects of weight modiﬁcations through diet or
bariatric surgery on obesity-related reproductive dysfunction. In this regard, several studies have demonstrated that weight
loss has been associated with a restoration of gonadal hormones levels.
Introduction
Obesity is a worldwide epidemic disease, affecting more
than 650 million adults [1]. Overall, about 13% of the world
adult population were classed as being obese in 2016 [1].
According to the World Health Organization, excessive
weight and obesity are deﬁned as abnormal accumulation of
fat that represents a health risk [2]. Obesity has been
reported to be associated with cardiovascular disease, sleep
apnea, osteoarthritis and some types of cancer [3]. Further,
erectile dysfunction, low testosterone concentrations and
infertility can also be observed.
The association between obesity and male reproductive
dysfunction is reported in epidemiological studies [4].
Azoospermia and oligospermia are more prevalent among
males with obesity compared with those without obesity [5].
Some studies from northern Europe report an adjusted odds
ratio for infertility at 12 months between 1.36 and 1.53 for
males with obesity compared to those of normal weight [6].
Obesity is associated with an increased time to conception
and reduced pregnancy rates [7]. This review explores the
impact of obesity on male reproductive function providing an
overview of the human studies and the potential treatment.
Obesity and hormonal disorders
The best known effect of obesity on male reproductive
function is secondary hypogonadism [8]. This is char-
acterized by low testosterone (<12.1 nmol/l) associated with
signs and symptoms of hypogonadism, such as reduced
sexual desire and activity, decreased spontaneous erections,
loss of body (axillary and pubic) hair, reduced shaving,
impaired spermatogenesis with reduced levels of inhibin B
and low/normal FSH and LH concentration [9].
Here, we outline all the factors hypothesized to be
responsible for secondary hypogonadism in males with
* Giuseppe Bellastella
giuseppe.bellastella@unicampania.it
gbellastella@hotmail.com
1 Unit of Endocrinology and Metabolic Diseases, Department of
Advanced Medical and Surgical Sciences, University of Campania
‘Luigi Vanvitelli’, Naples, Italy
2 Department of Clinical Medicine and Surgery, ‘Federico II’
University of Naples, Naples, Italy
3 Department of Experimental Medicine, ‘Sapienza’ University of
Rome, Rome, Italy
12
34
56
78
90
()
;,:
12
34
56
78
90
();
,:
obesity. In particular, we propose a new classiﬁcation in
which we identify some central, peripheral and testicular
factors (Fig. 1).
Central factors
With the term ‘central factors' we mean all the mechanisms
and the disorders affecting the hypothalamic—pituitary axis
activity. The main mediators originate from excess of adi-
pose tissue, which induces a chronic inﬂammation state
associated with an insulin and leptin resistance [10].
Inﬂammatory mediators
Tumour necrosis factor (TNF-α) and Interleukin-1B (IL-1B)
are inﬂammatory mediators that contribute to low grade
chronic inﬂammation and at the same time to suppress
hypothalamic GnRH secretion and LH secretion in vitro [11].
IL-1 (especially IL-1β, more than IL1-α) potently suppresses
LH release through blockade of GnRH secretion [12], by
inhibiting the translational efﬁciency of the GnRH mRNA
[13]. The prospective, randomized, placebo-controlled trial
TestIL is currently ongoing to investigate the hypothesis that
the blockade of IL-1 activity diminishes its inhibitory effect
on the hypothalamic-hypophyseal-gonadal (HPG) axis and
increases testosterone levels in men with metabolic syndrome
(Clinical Trial.gov, NCT02672592). The role of IL-6 is still
debated. Although an in vivo study reported an inhibitory
effect of IL-6 on LH secretion [14], other reports did not
conﬁrm this effect [14]. However, in vitro studies demon-
strated sex-related differences in the effects of IL-6 on
pituitary LH release in rats [15]. Several in vivo studies
demonstrated that TNF-α plays an inhibitory effect on the
GnRH-LH system [13, 14]. Also C-reactive protein (CRP)
may contribute to the suppression of the HPG axis and may
also worsen insulin resistance interfering with insulin signal
transduction [16].
Insulin resistance
Insulin resistance may be considered the second most
relevant causative factor in obesity-induced hypogonadism.
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Fig. 1 Central, peripheral and testicular factors that contribute to impair the HPG axis function
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It is known from cell culture studies that insulin stimulates
the HPG axis activity at several levels, i.e., hypothalamic,
pituitary and testicular levels [16]. Insulin resistance may
also affect hypothalamic neurons and consequently the
GnRH secretion [17]. This hypothesis is supported by some
studies on animal models. In particular, the neuron-speciﬁc
insulin receptor knock-out male mice show a 60–90%
decrease in serum LH concentration [18]. Therefore, the
maintenance of the functional integrity of the HPG axis
needs a correct insulin metabolic pathway in the brain.
Leptin resistance
Leptin is a hormone secreted by adipocytes that not only
stimulates the satiety center but also acts as a neuroendo-
crine hormone in regulating sexual maturation and repro-
duction [9]. Leptin may act as a central or peripheral factor
(see below). The central role is due to the presence of leptin
receptors on kiss1 neurons that are able to stimulate GnRH
secretion. Leptin is also able to negatively control Neuro-
peptide Y(NPY) expression and then to prevent the NPY
neurons from inhibiting GnRH release [19]. Some authors
hypothesized that the leptin excess in obese males and in
particular in those with impaired fertility drives the HPG
axis to become leptin resistant [20]. This effect results in
reduced GnRH, FSH and LH release and consequently
impaired spermatogenesis.
Kisspeptin
Kisspeptin is a hypothalamic peptide encoded by the KiSS1
gene, a gene that was ﬁrst described in 1996 as associated
with human malignant melanoma [21]. Since its ﬁrst
description, kisspeptin was recognized as an important
neuromodulator with a key role in the HPG axis and fertility
control. In humans, most of the kisspeptin cells are loca-
lized at the hypothalamic level, especially in the infundib-
ular nucleus and in the rostral preoptic area [22], even if
kisspeptin traces have been identiﬁed also in peripheral
tissues, as the testis, ovary, pancreas and small bowel.
Through its G-protein coupled receptor KISS1R (also called
GPR-54) kisspeptin increases delivery of GnRH into the
portal circulation which enhances the secretion of LH and
FSH from the anterior pituitary cells [23]. It has been shown
that administration of exogenous intravenous kisspeptin-54
infusion in healthy men stimulated a signiﬁcant increase of
serum LH, FSH and testosterone concentrations compared
with saline infusion [24]. In hypogonadal men with type 2
diabetes kisspeptin-10 infusion increased LH frequency and
amplitude, with an associated increase in serum testosterone
[25]. A decreased endogenous kisspeptin secretion plays a
central role in mediating obesity-related hypogonadotropic
hypogonadism (HH). Experimental studies have shown that
a high fat diet (HFD) and central leptin resistance determine
a marked decrease in kisspeptin expression both in the
rostral periventricular region of the third ventricle and the
arcuate nucleus in mice models [26]. Another experimental
study showed that mice with diabetes type 1 had alteration
in kiss1 and/or GPR-54 mRNA expression in both kis-
speptin neurons and peripheral tissues (fat, pancreas and
liver) [27]. This is an important issue for potential future
pharmacological therapies based on kisspeptin analogue to
treat HH.
Autoimmunity
It has been reported that there is an increased risk of
some autoimmune diseases in people with obesity [28].
A possible role of pituitary autoimmunity as a pathophy-
siological mechanism for HH in obese males has so far not
been investigated, but it may not be excluded, even
because HH has been frequently observed in patients
with autoimmune hypophysitis, positive for antipituitary
antibodies targeting gonadotropin-secreting cells [29].
Moreover, pituitary antibodies to pituitary gonadotropin-
secreting cells have been demonstrated in patients with
type 2 diabetes mellitus (T2DM) [29]. Obese patients, on
one hand, are prone to inﬂammatory processes due to
increased levels of inﬂammatory mediators which can
favour also pituitary autoimmunity [30], on the other
hand they are prone to develop T2DM. On these bases,
cross-sectional and longitudinal studies investigating the
occurrence of pituitary autoimmunity in obese patients is
advisable.
Peripheral factors
We mean with this term all the factors and conditions
determining a peripheral change in sexual hormones con-
centrations and consequently affecting central and testicular
function.
Leptin
Leptin is higher in obese than in non-obese males.
The peripheral effects include a direct possible inhibitory
effect on Leydig cells and then on testosterone production
[19]. Moreover, leptin may reduce the Leydig cell
responsiveness to LH stimulation mediated by the
expression of its receptor in testicular tissue and in
seminal ﬂuid. Increase of leptin levels might directly
affect spermatogenesis and seems to favor germ cell
apoptosis in testes [31]. In human males, leptin is nega-
tively correlated with total and free testosterone levels
resulting a good predictor of impaired androgen secretion
in people with obesity [31].
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Sex hormone-binding globulin (SHBG)
SHBG, released by the liver, binds testosterone with
high afﬁnity and its concentrations are inversely correlated
with body mass index (BMI) [32]. Obese males who
develop insulin resistance and consequently hyper-
insulinemia are at higher risk of low SHBG concentrations
[33], because hyperinsulinemia suppresses hepatic produc-
tion of SHBG [17]. The reduction of SHBG levels causes
also a decrease in testosterone concentrations affecting its
half-life [34], and an increased availability of free testos-
terone levels, a good substrate for aromatase to be converted
to oestradiol. Indeed, aromatase activity is abundant in
adipose tissue with consequent higher conversion of tes-
tosterone into oestradiol (testosterone-oestradiol shunt)
[35]. The reduction of SHBG and the increase of aromatase
activity determine a rise in oestradiol concentrations that
have an inhibiting effect on central function (hypothalamic-
pituitary function) [18].
Erectile dysfunction
Erectile dysfunction (ED) is a frequent complication [33] in
men with obesity. Some studies show that obesity and, in
particular, central obesity is associated with atherogenic ED
[33]. Waist circumference has been shown to be a better
predictor of ED than BMI [36]. We decided to include ED
in the list of peripheral factors involved in hormonal dys-
function because of its role on coital frequency and con-
sequently on testosterone levels and fertility [4]. In this
regard, we support the hypothesis that sexual behaviour can
exert a feedback action to hormone levels [37]: orgasmic
frequency in males, whether through masturbation or coitus,
is positively correlated with free and total testosterone [37].
Obstructive sleep apnea (OSA)
OSA is a condition characterized by frequent proximal
airway obstruction resulting in apnea, hypopnea, oxygen
desaturation [38]. OSA and the consequent sleep fragmen-
tation produces a reversible dysfunction of the HPG axis
[39]. Patients with OSA show lower free and total testos-
terone [40] with suppression of their nocturnal testosterone
rise [41]. Moreover, it has to be considered a possible
desynchronization of circadian rhythmicity with reduction
of nocturnal increase of LH pulsatility and consequently
reduction of testosterone secretion [42]. Obese patients
usually have disorders in eating habits. This can induce
further alterations of the internal clock [42] with consequent
further impairment of HPG secretions. Finally, it may not be
ignored that there is a possible desynchronization of the
circannual testosterone rhythm in obese males, as occurring
in other forms of hypogonadism [43].
Gut endotoxin
Obesity and high fat and high energy diets cause a break-
down in normal intestinal mucosal barrier function that then
facilitates the passage of gut bacteria from the bowel lumen
into the systemic circulation [44, 45]. This causes a chronic
state of low grade inﬂammation that impairs testicular
function and reproductive performance [45].
Testicular factors
In the previous sections, we described central and peripheral
factors that may potentially affect testicular function. In this
section we report obesity-related conditions developing into
the scrotum that may locally affect testicular function.
The abdominal, suprapubic and medial thigh fat,
wrapping the scrotum, leads to an increase in intrascrotal
temperature determining an increased DNA fragmentation
and an increased oxidative stress [9, 40, 46]. This nega-
tively impacts on the sperm quality; the elevation in scrotal
skin temperature has been associated with reduced sperm
motility and concentration [46].
The hyperthermia may also affect other intrascrotal
structures such as the epididymis that may be affected by
inﬂammation [47]. The inﬂammation of the epididymis may
impair epididymal function by altering sperm maturation and
fertilization ability. The epididymal structure may be altered
by inﬂammation (on one or both side) until cyst formation,
ducts obstruction, scarring and ﬁbrosis [46].The testes have a
speciﬁc sensor of energy reserves, the 5′AMP-activated
protein kinase (AMPK) sensitive to energy abundance as
seen in obesity or energy restriction. It is present in Sertoli,
Leydig and germinal cells. The sensor plays a crucial role in
the regulation of gonadal steroidogenesis, in the proliferation
and survival of somatic gonadal cells, as well as in the
maturation of spermatozoa [47].
Obesity and spermatogenesis
In vitro and animal studies
Several lines of evidence from animal models have demon-
strated a deleterious effect of obesity on sperm number and
quality. In a study on an animal model of obesity, neonatal
male rats were treated with monosodium glutamate, which is
able to induce obesity causing alterations in the hypothalamic
arcuate nucleus and impairing leptin and insulin signalling in
this region. When compared to non-treated animals, obesity
led to a signiﬁcant decrease in the numbers of testicular
spermatids and spermatozoa and a signiﬁcant decrease in
daily sperm production. Moreover, the acceleration of sperm
transit time can affect spermatozoa maturation reducing
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sperm quality of these rats [48]. Also sperm mobility in rats
seems to be correlated to a decreased percent of sperm with
progressive motility [49].
One possible mechanism by which obesity can affect
sperm quality may be elevated oxidative stress in sperma-
tozoa, causing elevated levels of sperm DNA damage and
loss of function. In animal studies, the percentage of motile
spermatozoa and intracellular reactive oxygen species
(ROS) was decreased in the HFD group when compared
with controls. Moreover, sperm DNA damage was also
increased in the HFD group compared with the control
group, and this parameter has been linked to poor repro-
ductive outcome. The number of sperm bound to each
oocyte was signiﬁcantly reduced in the HFD group com-
pared with controls and it resulted in signiﬁcantly lower
fertilization rates [50]. An interesting study has evaluated
sperm quality in 4 groups of mice: control group, HFD
group, restricted high fat diet group (RHFD) and restricted
high fat diet group with antioxidants consumption
(RHFDA) (astaxanthin, vitamins E and C group) [51].
Sperm number, viability, motility and normal morphology
of the sperms in the HFD, RHFD, and RHFDA groups were
signiﬁcantly lower than the control group. Interestingly,
sperm motility of the RHFDA group was decreased sig-
niﬁcantly compared to the control group but was sig-
niﬁcantly higher than HFD and RHFD groups, conﬁrming
that ROS may play a role in sperm alteration due to obesity
[51].The detrimental effect of ROS on spermatogenesis has
been demonstrated also in human spermatozoa, which are
known to be susceptible to lipid peroxidation because of
their high contents of unsaturated fatty acids [52].
Animal models have also been used to demonstrate the
effects of obesity on sperm chromatin integrity [53]. In diet-
induced obesity and leptin deﬁcient obesity there was an
increased sperm DNA fragmentation compared to lean mice
[53]. The examination of the transcriptional response of a
selection of marker genes in the testis by quantitative real-
time PCR, showed moderate, but signiﬁcant, up-regulation
of the Cyp2e1, Cyp19a1, TNF and PPARγ genes in obese
mice compared to lean mice, suggesting a local response in
testicular cells to the HFD regimen with a potential impact
on and spermatogenesis [53]. Obesity is also able to alter
seminal vesicle ﬂuid composition in a mouse model [54],
increasing levels of insulin, leptin and reducing levels of
oestradiol in seminal vesicle ﬂuid.
Obesity reduced the quality of sperm also by changing
inﬂammatory proﬁle. Obese mice fed with HFD showed an
increased mRNA expression levels of TNF-α, MCP-1, and
F4/80 in testis while exenatide administration has shown to
improve the quality of sperm through a reduction in the
expression of pro-inﬂammatory cytokines [55]. Moreover,
in vitro studies have demonstrated how inﬂammatory cyto-
kines, as TNFα, IL-1, IL-6 produced by the white adipocytes,
may affect directly spermatogenesis by various mechanisms:
alteration in blood-testis barrier by impairing gap junctional
communication in Sertoli cells [56], reduction in spermato-
gonia cellular differentiation, inhibition of meiotic DNA
synthesis and reduction in sperm motility [57].
Human studies
Obesity and sperm concentration and quality
Several studies have investigated the impact of male obesity
on the normal sperm physiological parameters, reporting
controversial results. A reduction in sperm count have been
demonstrated in obese subjects [58]. In a study on 225 male
partners of pregnant women (16–32 weeks) who conceived
naturally, obesity (BMI > 30 kg/m2) was signiﬁcantly related
to total sperm count. Compared with those with BMI < 30 (n
= 188), people with obesity (n= 35) had signiﬁcantly lower
total sperm count [59]. A study on 7630 male subjects
in Taiwan (of which 31.4% were overweight or obese),
investigating the correlation between BMI and other
anthropometric indexes and semen quality [60], showed a
signiﬁcantly negative linear association between sperm con-
centration and BMI. In the same study, visceral adiposity,
estimated by waist circumference, seemed to affect sperm
concentration, sperm morphology but not sperm motility.
Coherently, another study on 2035 patients (18 under-
weight (1%), 839 (41%) normal weight, 909 (45%) over-
weight and 269 (13%) obese men), normal sperm
morphology was signiﬁcantly higher in normal-weight and
underweight groups compared with overweight and obese
groups, after correction for age, abstinence period and social
deprivation [61]. Progressive motility was not associated
with BMI [61].
In another study on 1248 subjects enrolled in a clinic for
reproductive treatment or specialized in medical pre-
conception care, overweight and obesity seemed to affect
also sperm motility [62]. Overweight was negatively asso-
ciated with the percentage of progressive motility type A
and positively associated with the percentage of immotility
type C. Obesity was negatively associated with sperm
concentration and total motile sperm count after adjustment
for age, ethnicity, active and passive smoking,
alcohol, medication use and folate status [62]. Waist cir-
cumference ≥ 102 cm, a measure for central adiposity, was
inversely associated with sperm concentration and total
motile sperm count [62]. The negative impact of obesity on
sperm quality is still poorly understood at the molecular
level. An interesting study has recently analysed differences
between the proteomes of spermatozoa obtained from
obesity-associated asthenozoospermic and normozoos-
permic individuals using label-free quantitative LC-MS/MS
proteomic analysis [63]. The study demonstrated declines in
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ERp57 and ACTRT2 expression in obesity-associated
asthenozoospermia; in fact these two protein may play
critical roles in reducing sperm motility [63]. Obesity causes
also a reduction in sperm volume compared with normal
weight men [62].
On the contrary, other studies showed no effect of obesity
on sperm parameters. For example, in a study on 2110 men
attending infertility work-up sperm motility, morphology
and concentration were not signiﬁcantly different in groups
with different BMI levels [3]. Similarly, in the LIFE study,
BMI and waist circumference showed no correlation with
semen concentration, motility, vitality, morphology or DNA
fragmentation index. Only ejaculate volume and, conse-
quently, total sperm count showed a linear decline with
increasing BMI and waist circumference [64].
Three meta-analysis were performed to investigate the role
of overweight and obesity on sperm parameters. The ﬁrst
one, published in 2010 by McDonald et al., analysed data on
a total of 6793 men, failing to demonstrate a statistically
signiﬁcant relationship between BMI category and mean and
median sperm concentration, mean and median total sperm
count, mean semen volume or average sperm motility [65].
The meta-analysis published in 2013 by Sermondade
et al., analysing data on 13,077 men, showed a J-shaped
association between BMI and abnormal sperm count:
underweight was associated with an increased but non-
signiﬁcant risk of abnormal sperm count, whereas overweight
and obese men had a signiﬁcantly elevated risk of abnormal
sperm count compared with normal weight men [66].
The contrast between these two meta-analyses can be
explained by the higher number of studies included in the
second meta-analysis and the choice of dichotomizing
sperm concentration (oligozoospermia or azoospermia)
instead of trying to correlate BMI and sperm count. In 2017,
another meta-analysis was performed [67], demonstrating a
decreased total sperm count and semen volume in over-
weight patients and a decrease of total sperm count, sperm
concentration and semen volume in obese patients, while no
variation in sperm motility was demonstrated.
One mechanism proposed to explain why overweight
and obesity may affect sperm quality is a direct action of
obesity on Sertoli cell function, as indicated by reduced
levels of inhibin-B in obese patients [68]. The effect of
obesity on inhibin-B is established during puberty, because
values of inhibin-B are normal in obese prepubertal boys.
Considering that Sertoli cell is thought to support a ﬁnite
number of germ cells, fewer Sertoli cells in obesity may
predispose to a lower sperm count in adulthood [68].
The increase of testicular temperature caused by hip
and abdominal fat tissue accumulation, but also by high
fat content in scrotum area, has been hypothesized as cause
of spermatogenesis disorders [69]. Obesity causes a reduction
in the levels of some fatty acids in spermatozoa
(docosahexaenoic acid, palmitic acid) associated with an
increase in DNA fragmentation index and a reduction in total
sperm count, sperm vitality and sperm motility [70]. Another
potential underlying pathological mechanism of diminished
reproductive performance in obese men could be sperm oxi-
dative stress, which is increased in obese patients [71].
Finally, preferential accumulation of toxic substances
and liposoluble endocrine disruptors in fat tissue could
amplify the detrimental effects of these exogenous sub-
stances, as suggested by the direct correlation between
serum organochlorine levels and BMI [72] (Fig. 2).
Obesity and other sperm parameters
Several studies have demonstrated a higher frequency of
sperm DNA damage, in obese patients subjected to semen
analysis at fertility clinics [73].
In a study on 330 male partners of subfertile couples
presenting for semen analysis, DNA fragmentation rate,
after adjustment for age and tobacco use, was signiﬁcantly
higher in obese men than in lean ones. No increase in DNA
fragmentation was found in overweight men. Dividing
fragmentation rate in 4 categories, OR for moving from one
DNA fragmentation category to the next was 1.3 (0.8–2.1)
for overweight and 2.4 (1.2–4.7) for obese men [74].
Another study by Fariello et al., showed that obese men had
a higher percentage of sperm with high DNA fragmentation,
evaluating visually DNA damage, as assessed by comet tail
and nuclear intensity [75]. Another study on 520 healthy
men (mean age 34.6 years) presenting for routine semen
analysis demonstrated a signiﬁcant and positive relation
between BMI and DNA fragmentation index [76].
However, the current evidence is controversial. Rybar
et al. investigated sperm chromatin integrity (by sperm
chromatin structure assay) and quality of sperm chromatin
condensation (by toluidine blue, aniline blue and chromo-
mycin A3 staining) without ﬁnding any differences in the
percentages of cells with defective chromatin in the over-
weight and obese patients compared with men with normal
BMI [77].
Mitochondrial activity seems to be impaired in obese
patients: in a study on 305 patients the obese group had a
lower percentage of sperm with mitochondrial activity DAB
class II (>50% of the midpiece was stained) and a higher
percentage of DAB classes III and IV,(sperm with low or
zero mitochondrial activity) [75]. In a study on 212 healthy
men, aiming to identify which lifestyle factors were related
to sperm aneuploidy, obesity was associated with an
increase in the number of additional chromosome 21 as
compared to normal weight men [78].
In a group of 107 male patients, who was referred to the
fertility laboratory for diagnostic semen analysis or collec-
tion of a semen specimen for use for in vitro fertilization,
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BMI was inversely correlated with hyaluronan binding
score. This score is an indicator of completion of normal
spermatogenesis, which has been used to identify mature
sperm with normal chromosome development and oocyte-
binding capability [79].
Effect of male obesity on offspring health
In addition to the alteration in male fertility, obesity seems
to affect also offspring health. In animal studies it has been
demonstrated that paternal obesity and glucose intolerance
could directly impact the metabolic syndrome susceptibility
of the offspring [80]. In addition to the reported changes in
metabolic proﬁle in offspring, one study in a rodent model
of male obesity has also reported a negative effect of male
obesity on the reproductive health of male and female off-
spring extending to 2 generations [81]. Even if the exact
mechanisms of these transgenerational effects of male
obesity is not clearly understood, genetic association ana-
lyses suggest that the epigenome of multiple tissues is
inﬂuenced by adiposity [82]. Hence, sperm cells may carry
epigenetic changes, as methylation, which could be the
underlying cause of the alteration of offspring health [83].
Obesity and in vitro fertilization (IVF)
outcomes
Several studies analyzed the inﬂuence of male obesity on
success following assisted reproductive technologies
(ART). Most of the studies evaluated how men’s BMI
affects the outcomes of assisted fertilization. The study by
Provost et al. that examined in a large number of IVF cases,
the implantation rate, clinical pregnancy rate, live birth rate
and pregnancy loss, demonstrated that obesity in men sig-
niﬁcantly impairs the clinical pregnancy rate (reduction
from 45% in normal weight to 30% in patients with BMI >
50 Kg/m2) and increase pregnancy loss (from 8.8 to 20%
respectively in patients with normal BMI and in patients
with BMI between 45–49.9) [84]. Another study including
men with normal results from sperm tests showed an
inverse association between BMI and live birth rate after
ART [85]. Some differences have been found between
in vitro fertilization and intracytoplasmic sperm injection
(ICSI). The study by Keltz et al. showed a reduction of
clinical pregnancy if the male partner was overweight after
IVF but not after ICSI (odds ratio 0.21 vs 0.75 respectively)
[86]. From our literature revision it seems that only
one study concludes that the combination of an obese
male and a normal-weight female is positively related to
better implantation rates in IVF as well as ICSI cycles.
The authors afﬁrm that this combination is more likely to be
found in couples with a higher social status [2].
Effects of weight loss on male fertility
Diet effects
Only a few studies have evaluated the effect on reproduc-
tive hormones of restricted energy intake (Table 1). An
increase of androgen serum levels has been described after
Fig. 2 Physiopathology of
obesity-induced sperm
alterations
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weight-loss induced by LCD [87–90] and it has been
sometimes associated with estrogen decrease, but these
were not recent studies [91]. One study evaluated 38 obese
men and divided them into two groups: one group of
19 subjects was treated with 12 weeks very low calorie-diet
(VLCD), total energy intake of approximately 800 kcal/day)
and subsequent 10 weeks behavioural variation, the other
group of 19 untreated control subjects [87]. The rapid
weight loss induced by VLCD resulted in increase of
SHBG, testosterone, HDL-cholesterol and decrease of
insulin and leptin serum levels, and these changes were
maintained until the end of 8-month follow-up[87]; addi-
tionally, when the changes in metabolic and hormonal
variables induced by maintained weight loss were evaluated
in backward regression analysis, the decrease in insulin
resistance was the most signiﬁcantly related parameter to
serum testosterone levels [87]. These data suggest a crucial
role of increase of insulin-sensitivity in the restoration of the
eugonadal status in obese men.
A strong correlation between insulin-sensitivity increase
and testosterone levels has also been demonstrated by
another study which has evaluated sex hormones serum
levels, sexual function assessed through IIEF-5 score and
low urinary trait symptoms (LUTS) assessed through IPSS-
score in men with abdominal obesity with or without T2DM
compared to a control group of men without diabetes but
with similar body mass index and WC, before and after 8
week-low e diet (LCD), total energy intake of approxi-
mately 850–900 kcal/day) [88]. Weight loss signiﬁcantly
correlated with increase of insulin-sensitivity, total testos-
terone serum levels, IIEF-5 and sexual desire item (SDI)
scores; moreover, IIEF-5 and SDI scores were positively
associated with the magnitude of waist circumference
reduction, reﬂecting visceral fat accumulation [88]. IPSS
score was positively correlated with weight and abdominal
adiposity loss and reciprocally associated with IIEF-5 and
SDI score, suggesting that LUTS as well as sexual dys-
function in obese men might represent a feature of
abdominal obesity, being improved by weight and waist
circumference reduction [88]. These effects of diet-induced
weight loss were conﬁrmed in a cohort of 31 men with
obesity and diabetes, who experienced an improvement of
hormonal, sexual and urinary functions not only through an
initial 8-week low-calorie diet but also through an alter-
native 8-week initial and then a 44 week maintenance high-
protein, low-fat and reduced-carbohydrate diet (HP) pro-
gram based on a reduction in daily intake of approximately
600 kcal/day [89]. Additionally, this study demonstrated a
signiﬁcant decrease of CRP and IL-6, which represent
important inﬂammatory markers, and an improvement of
endothelial function assessed through soluble E-selectin
levels and brachial artery ﬂow-mediated dilatation increase;
[89] these further effects induced by diet-associated weight
loss suggest other mechanisms potentially involved in the
improvement of sexual and urinary function in obese men.
Finally, a study evaluated the effect of rapid weight loss
obtained through 9-weeks VLCD and 12 month-sustained
weight maintenance on sex hormones serum levels in a
cohort of 58 men with abdominal obesity [90]. SHBG
serum levels signiﬁcantly increased during weight loss
induced by VLCD and decreased during weight main-
tenance, remaining however higher than baseline levels;
free testosterone signiﬁcantly increased both during rapid
weight loss induced by VLCD and at the last of weight
maintenance 1 year-period, whereas total testosterone
showed an intermediate trend between SHBG and free
testosterone variations [90]. These ﬁndings emphasized the
importance of weight loss in the prevention of progressive
Table 1 Summary of studies on
the impact of weight loss
through diet, in men with
obesity: overall, weight loss
through diet improves sex
hormones levels, particularly
androgens and sex hormone
binding globulin, sometimes
sexual function and rarely
seminal parameters (semen
volume and total sperm count)
Authors TT FT E2 LH FSH SHBG TYPE and duration of weight loss
Kaukua [87] ↑ ↑ VLCD (4 months); no changes in sexual function
Khoo [88] ↑ LCD (8 weeks); improvement also in IIEF and IPSS
Khoo [89] ↑ ↑ LCD and HP (8 and 52 weeks); improvement in IIEF,
IPSS, FMD
Niskanen [90] ↑ ↑ ↑ VLCD (9 weeks) and maintenance period (12 months)
Stanik [113] ↑ ↓ Weight reduction (8 and 20 weeks)
Strain [114] ↑ ↑ ↑ Weight reduction (5 and 39 months)
Hakonsen [93] ↑ ↑ Weight reduction (14 months); improvement in AMH
serum levels, semen volume and total sperm count
Reis [97] No effect of exercise and diet for 4 months
Klibanski [92] ↑ ↓ ↓ Effect of fasting on sex hormones serum levels
TT total testosterone, FT free testosterone, E2 oestradiol, LH luteinizing hormone, FSH follicle stimulating
hormone, SHBG sex hormone binding globulin, VLCD very low calorie diet (800 kcal/day), LCD low calorie
diet (900 kcal/day), IIEF international index of erectile function, IPSS international prostatic symptoms
score, FMD brachial artery ﬂow-mediated dilatation, HP high protein-low fat diet (reduction by 600 kcal/
day), AMH anti müllerian hormone
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hormonal imbalance associated with obesity and high-
lighted the crucial role of lifestyle modiﬁcations as ﬁrst-line
treatment of male hypogonadism secondary to obesity [90].
Only one anecdotal study reported a negative effect of
diet on sex hormones serum levels, describing a combined
decrease of FSH, LH and testosterone after fasting in obese
men [92]; this could be explained by the excessive and
probably detrimental effects of fasting and fasting-
associated ketosis on metabolism and sex hormones [91].
The effects on semen quality of weight loss obtained
through non-surgical interventions have been poorly stu-
died. One study evaluated 43 men with obesity before and
14 weeks after a weight loss program based on healthy diet
and physical exercise [93]. Weight loss was signiﬁcantly
associated with an increase in total sperm count, semen
volume, total testosterone, AMH and SHBG serum levels;
moreover, the group of men with obesity with the largest
weight loss showed a signiﬁcant increase in total sperm
count and normal sperm morphology [93]. The results of
this study suggested that weight loss induced by non-
surgical interventions could improve semen quality of men
with obesity, even if further studies with a larger cohort and
a longer follow-up period are needed to establish if this
effect is really induced by weight loss per se or by a direct
contribution of general lifestyle modiﬁcation [93].
Bariatric surgery effects
Several studies have analysed the impact of bariatric sur-
gery on sex hormones in men with obesity, by demon-
strating, overall, a positive effect of weight loss induced by
bariatric surgical intervention on sex hormones serum levels
(Table 2).
Several studies have demonstrated an increase of total
testosterone serum levels after weight loss obtained through
bariatric surgery, and the improvement in total testosterone
serum levels was inversely correlated with fasting glucose
and insulin serum levels, conﬁrming that insulin-sensitivity
and androgen serum levels might be positively associated
[94, 95]. Moreover, the increase in total testosterone levels
was negatively associated with hyperestrogenism and leptin
serum levels, therefore conﬁrming their role of crucial dis-
ruptors of HPG axis in men with obesity [94, 96]. Lastly,
the improvement of testosterone serum levels was found to
be associated with waist circumference reduction [97]. The
association between hypogonadism and visceral obesity has
been extensively investigated. A remarkable prospective
study evaluating a cohort of 55 men with obesity under-
going bariatric surgery, which included 29 affected by
hypogonadism and 26 who were eugonadal, demonstrated
that total testosterone serum levels were increased after
bariatric surgery, in both hypogonadal and eugonadal
groups, and that the increase in total testosterone serum
levels was strongly correlated to the reduction of waist
circumference in hypogonadal patients [97]. Moreover, a
longitudinal assessment of results showed that hypogonadal
patients with obesity had a higher waist circumference at
baseline, and a larger waist circumference reduction after
bariatric surgery, compared to men who were eugonadal
[97]; the results of the study suggested that hypogonadism
might have a possible role of predictor of waist cir-
cumference reduction after surgical intervention [97]. Total
testosterone increase has often been associated with the
increase in calculated free testosterone, assessed with Ver-
meulen formula [95, 97], and, in turn, free testosterone
increase has been correlated with fasting glucose [94] and
Table 2 Summary of studies on the impact of bariatric surgery on sex hormones and sexuality, in men with obesity: bariatric surgery improves sex
hormones levels, particularly, androgens, but also estrogens, gonadotropins and sex hormone binding globulin
Authors TT FT E2 LH FSH SHBG Notes
Botella- Carretero [95] ↑ ↑ ↑ Increase of FT strongly associated with reduction in IR
Aarts [98] ↑ ↑ FT as a possible marker of hypogonadism in men with obesity
Alagna [96] ↑ ↑ ↓ ↑ ↑
Bastounis [103] ↑ ↓ ↑ ↑
Hammoud [101] ↑ ↑ ↓ Increase of sex hormones correlates with increase in sexual function
Reis [97] ↑ ↑ ↓ ↑ 24 months after bariatric surgery, also increase in sexual function
Rosenblatt [104] ↑ ↑ ↑ 6 years after bariatric surgery, no association with increase in sexual function
Samavat [106] ↑ ↑ ↓ ↑ >WC at baseline in severe hypogonadism is associated with >reduction of WC after
surgery
Calderon [94] ↑ ↑ ↑ FT strongly associated with reduction in IR; no differences between surg. Gastric
bypass and restrictive technique
Pellittero [105] ↑ ↑ ↓ ↑ ↑ 12 months after bariatric surgery; increase in inhibin B and AMH, also in case of
decrease at baseline
TT total testosterone, FT free testosterone, E2 oestradiol, LH luteinizing hormone, FSH follicle stimulating hormone, SHBG sex hormone binding
globulin, IR insulin-resistance, WC waist circumference, AMH anti müllerian hormone
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improvement in insulin-resistance, assessed with the
HOMA-index [95]. Considering that total testosterone
decrease is often associated to SHBG serum levels reduc-
tion in men with obesity, one study highlighted that free
testosterone might be a better diagnostic marker for hypo-
gonadism, aimed at preventing overestimation of this con-
dition in obesity [98]. In line with this assumption, several
studies have demonstrated a signiﬁcant increase of SHBG
serum levels after weight loss obtained through bariatric
surgery [95, 99], and found a negative correlation between
SHBG, insulin-resistance and visceral adiposity and hepatic
fat [90, 100], conﬁrming the crucial link in men with obe-
sity between insulin-resistance improvement and restoration
of eugonadal status [97].
Sexual and erectile function have been frequently cor-
related to androgenic status, and an overall improvement in
sexual function has been reported after weight loss obtained
through bariatric surgery [101, 102], probably due to
recovery from hypogonadal status [103], amelioration of
obesity comorbidities, such as metabolic syndrome and
hypertension, known as erectile dysfunction organic pro-
moters [101], and improvement of psychological proﬁle
after weight loss. Conversely, one study reported no
improvement of sexual function after bariatric surgery,
pinpointing the residual overweight and the persistence of
obesity comorbidities as leading causes of unchanged sex-
ual function [104].
A signiﬁcant decrease of estrogen serum levels has been
consistently observed in men with obesity, after bariatric
surgery [96, 99, 105, 106], and has been found to be mainly
induced by the reduction of adipose tissue-associated aro-
matase activity, which is responsible of hyperestrogenism in
these men [96, 99, 105]. The reduction of estrogen serum
levels induced by bariatric surgery determines the sup-
pression of estrogen-mediated negative feedback on
the HPG axis, as demonstrated by LH [96, 106] and FSH
[96, 99, 105, 106] increase and contributes to the restoration
of eugonadal status after bariatric surgery-induced weight
loss [95, 96, 99, 105]. Hyperestrogenism in men with
obesity has been interestingly correlated with down-
regulation of GLUT4 (glucose transporter-4), a molecular
target mediating peripheral insulin-sensitivity [94], there-
fore suggesting that hyperestrogenism might be involved in
increased insulin-resistance in these men, and that the
decrease in estrogen serum levels induced by bariatric sur-
gery might contribute to improve insulin-sensitivity [94].
There is little evidence about the effects of bariatric
surgery on AMH and inhibin B serum levels. One study
evaluated a cohort of 33 men prior to and 12 months after
bariatric surgery, by assessing serum levels of FSH, LH,
total and free testosterone, SHBG, prolactin, estradiol,
AMH and inhibin B; the results of the study demonstrated a
signiﬁcant improvement in FSH, total and free testosterone,
SHBG, prolactin and estradiol serum levels after bariatric
surgery [105]. At baseline, AMH and inhibin B serum
levels were lower in hypogonadal, compared to eugonadal
patients; after bariatric surgery, both AMH and inhibin B
serum levels were not signiﬁcantly changed, although
inhibin B showed a trend to an improvement, and a negative
correlation with BMI [105]. Moreover, in those cases
showing a lower-than-normal serum level of both AMH and
inhibin B at baseline, a complete normalization of the two
hormones was observed after bariatric surgery, suggesting
that weight loss induced by bariatric surgery might restore
normal AMH and inhibin B serum levels [105, 107];
however, few studies addressed this hormonal effect, and
further investigations concerning variations in AMH and
inhibin B levels after bariatric surgery are needed, in order
to better deﬁne whether Sertoli cell dysfunction occurs in
men with obesity, and whether weight loss induced by
bariatric surgery might exert beneﬁcial effects.
Lastly, bariatric restrictive interventions, such as sleeve
gastrectomy, and bariatric gastric bypass interventions, did
not signiﬁcantly differ in regard to their impact on sex
hormones serum levels [94]. Furthermore, the impact of
bariatric surgery on sex hormones was more signiﬁcant than
that of weight loss diet programs, probably due to less
pronounced and less durable weight loss obtained through
non-surgical interventions, compared to that achieved by
bariatric surgery interventions [108].
Despite several studies having demonstrated the impact
of bariatric surgery on hormonal proﬁle, the effect of
massive weight loss induced by bariatric surgery on seminal
parameters is still unclear. Some anecdotal case reports
highlighted the existence of a negative effect of bariatric
surgery on semen quality, probably associated with
malabsorptive complications of bariatric surgery [109–111].
Cases of azoospermia with spermatozoa maturation arrest
were described in a study evaluating six men after surgical
intervention by Roux-en-y gastro-intestinal bypass [109],
two cases of impaired semen quality have been reported
twelve and eighteen months after bariatric surgery, com-
bined with a subsequent decrease of ART outcome [110],
and three case reports have described a negative impact of
bariatric surgery on seminal parameters, although two of
these reports described a successful pregnancy obtained
through ICSI in obese subjects [111].
A 24 months-prospective, randomized, and controlled
study on 20 men with obesity who underwent a four-month
lifestyle modiﬁcation followed by surgical intervention of
gastric bypass, matched to men with obesity in clinical
follow-up, investigated the relationship between semen
quality and surgery-induced weight loss [102]; the results of
the study highlighted that bariatric surgery had no sig-
niﬁcant impact on semen quality, although this lack of an
effect might be explained by the small number of patients
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enrolled in the study [102]. Conversely, two recent pro-
spective interventional studies have demonstrated a positive
impact of bariatric surgery on semen quality [106, 112]. In
one study, semen quality and sex hormones levels were
evaluated in a cohort of 46 men prior to and twelve months
after sleeve gastrectomy [112]. Patients were divided into 3
groups on the basis of their different seminal proﬁle at
baseline, azoospermia was detected in 13 patients (28.3%),
oligozoospermia in 19 patients (41.3%), and normal sperm
concentration in 14 patients (30.4%); twelve months after
bariatric surgery, serum total testosterone increased in all
groups, whereas an improvement in sperm concentration
was observed only in azoospermic and oligospermic
patients, with sperm retrieval in 6 out of 13 patients (46%)
who initially had azoospermia [112]. Sperm motility and
normal morphology did not signiﬁcantly change after sur-
gery, although a trend towards improvement was reported;
similarly, no signiﬁcant differences were reported in other
sex hormones levels [112]. The results of this study suggest
that bariatric surgery might be more effective in improving
semen parameters in men with obesity with a worse semen
quality at baseline, although a limitation of the study
included the lack of an assessment of sperm DNA integrity
alteration a possible pathophysiologic mechanism of infer-
tility in men with obesity [112]. In line with this evidence,
another recent two-armed prospective study evaluated 31
men with morbid obesity undergoing laparoscopic gastric
bypass (n= 23), or in clinical follow-up (n= 8), by asses-
sing sex hormones serum levels, conventional (sperm count,
motility, and morphology and semen volume), and uncon-
ventional (sperm DNA fragmentation and IL8 seminal
levels) semen parameters, at baseline, and 6 months after
bariatric surgery or patients recruitment [106]. The results
demonstrated a signiﬁcant improvement of sex hormones
serum levels (FSH, LH, total testosterone, SHBG, calcu-
lated free testosterone, and estradiol), semen volume and
sperm viability, after bariatric surgery, compared to control
group [106]; moreover, a trend towards an improvement of
sperm motility total sperm count, IL8 seminal levels and
sperm DNA fragmentation as well as a trend towards an
increased prevalence of normozoospermia, were described
[106]. The improvement of seminal parameters was
strongly correlated with BMI decrease, which represented
the most inﬂuencing factor on seminal variations in uni-
variate and multivariate analysis [106]. The results of this
study suggest that changes in seminal parameters after
bariatric surgery are less pronounced, compared to changes
in sex hormones levels, and could be mediated by both post-
testicular mechanisms, as suggested by the decrease of
IL8 seminal levels and sperm DNA fragmentation, which
can be interpreted as markers of post-testicular inﬂamma-
tion, and testicular mechanisms, which however still remain
unclear [106, 107].
Conclusions
The current review provides an overview of the mechanisms
impairing sex hormones and seminal quality in men with
obesity and discusses the reversibility of these effects
through non-surgical and surgical weight-loss programs.
Male secondary hypogonadism is identiﬁed as one of the
most relevant hormonal complications of obesity; this
endocrine disorder can be induced by the complex interplay
of multiple central, peripheral and testicular factors, which
alter the normal function of HPG axis at different levels.
Impaired spermatogenesis represents another relevant
obesity-related andrological complication. Several pre-
clinical studies in animal models have recognized the
existence of a negative correlation between obesity and
semen quality, probably due to increased seminal oxidative
stress, sperm DNA integrity disruption, and increased local
release of inﬂammatory mediators within the reproductive
tract [48–53, 55–57]. Moreover, a decrease of pregnancy
rate after ART has been demonstrated in obese men [84–
86]. The evidence gathered by the current review demon-
strates a positive impact of weight loss in men with obesity
on both sex hormones serum levels and semen quality. LCD
signiﬁcantly improves sex hormones serum levels [87–90,
93, 113, 114], and, less consistently, sexual function [88,
89], whereas weak evidence exists about LCD-induced
improvement of semen parameters in obese men [93].
Weight loss after bariatric surgery, overall, is more sig-
niﬁcant and durable than LCD-induced weight loss; this is
probably the cause of the greater improvement of both sex
hormones serum levels and semen quality, in men with
obesity undergoing bariatric surgery [108]. Several
mechanisms have been found to be involved in the
improvement of hormonal proﬁle and seminal parameters,
after weight loss [104]. Visceral fat reduction and the
consequent increase of insulin-sensitivity [104, 111, 112],
as well as the reduction of hyperestrogenism negative
feedback on the HPG axis, and the decrease of leptin
serum levels [106, 114] have been all recognized as
major mechanisms of androgen increase after weight loss.
On the other hand, the mechanisms involved in the
improvement of seminal parameters after weight loss still
remain unclear. Both testicular and post-testicular factors
(reduction of scrotal temperature and reduction of seminal
accessory glands inﬂammation and inﬂammation-correlated
oxidative stress) have been hypothesized as possible med-
iators of the positive impact of weight loss on semen quality
[106, 107, 112].
Nevertheless, further preclinical and clinical studies are
needed to better deﬁne the entity of fertility impairment in
men with obesity, and to identify the underlying patho-
physiological mechanisms. Moreover, further randomized
and controlled clinical trials are mandatory to adequately
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estimate the clinical beneﬁts of weight loss by both LCD
and bariatric surgery on male fertility.
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